Market research
KIDS Orthopediatrics Corp
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 670M
- P/E ratio
- Not available
- Analyst target
- 27.2222
- Dividend yield
- Not available
- Beta
- 0.96
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US68752L1008
- Market cap
- 670M
- P/E ratio
- Not available
- Analyst target
- 27.2222
- Dividend yield
- Not available
- Beta
- 0.96
About
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the KIDS discussion.
5 years, 4 months ago
OrthoPediatrics Corp is currently in a long term uptrend where the price is trading 21.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.4.
OrthoPediatrics Corp's total revenue sank by 0.1% to $19M since the same quarter in the previous year.
Its net income has dropped by 158.1% to $-14M since the same quarter in the previous year.
Finally, its free cash flow grew by 49.3% to $-4M since the same quarter in the previous year.
Based on the above factors, OrthoPediatrics Corp gets an overall score of 3/5.